Barely Significant
← all excerpts

Targeting of the Lipid Metabolism Impairs Resistance to BRAF Kinase Inhibitor in Melanoma.

Front Cell Dev Biol · 2022 · PMC9326082 · PMID 35912092

Europe PMCDOI
1
hedged sentence
0.1000
closest p · 2.0× alpha
0.1000
boldest claim

The sentences

showed a trendp ≤ 0.1so close (0.05 < p ≤ 0.1)
In addition, the metabolic modules “C5 isoprenoid biosynthesis, mevalonate pathway”, “FA biosynthesis and elongation” and “Cholesterol biosynthesis” associated to the pathways of terpenoid, FA and steroid synthesis showed a trend of modulation ( p ≤ 0.1) ( Supplementary Table S2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.